Brompheniramine Maleate + Phenylpropanolamine HCl

Brompheniramine Maleate + Phenylpropanolamine HCl
Product Description

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes brompheniramine maleate + phenylpropanolamine HCl. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Read more Show less

Osmopharm S.A.

  • CH
  • 2015
    On CPHI since
View company profile
Specifications
  • Details
    Dosage: 4 mg + 50 mg.
More specifications Fewer specifications

Osmopharm S.A.

  • CH
  • 2015
    On CPHI since
View company profile

More Products from Osmopharm S.A. (99)

  • Atenolol

    Product Atenolol

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes atenolol. It belongs to antihypertensive category. Bulk physical form: pellets, microcapsules. Final dosage form: caps/tabs. Contact us for more information.
  • Benproperine

    Product Benproperine

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes benproperine. It belongs to antitussive category. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.
  • Betahistine 2HCI

    Product Betahistine 2HCI

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes betahistine 2HCI. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Bromopride

    Product Bromopride

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes bromopride. It belongs to antiemetic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Brompheniramine maleate

    Product Brompheniramine maleate

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes brompheniramine maleate. It belongs to antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Brompheniramine Maleate + Phenylephrine HCI

    Product Brompheniramine Maleate + Phenylephrine HCI

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes brompheniramine maleate + phenylephrine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Caffeine

    Product Caffeine

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine. It belongs to CNS stimulant category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Caffeine + Dimenhydrinate + Phenylephrine HCI

    Product Caffeine + Dimenhydrinate + Phenylephrine HCI

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine + dimenhydrinate + phenylephrine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Caffeine + Diphenihydramine HCl

    Product Caffeine + Diphenihydramine HCl

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine + diphenihydramine HCl. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Caffeine + Meclozine + Pyridoxine HCI

    Product Caffeine + Meclozine + Pyridoxine HCI

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine + meclozine + pyridoxine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Carbetapentane citrate

    Product Carbetapentane citrate

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbetapentane citrate. It belongs to antitussive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Carbinoxamine maleate

    Product Carbinoxamine maleate

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbinoxamine maleate. It belongs to antihistaminic category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.
show all 99 other products